Melanie Senior

Melanie Senior is an experienced biopharma reporter and science writer currently working at Nature Portfolio since January 2018, specializing in groundbreaking scientific advancements and vaccine developments. With a strong background in life sciences writing for various prominent organizations, including Evaluate Ltd, Nature, and Pharma and biotech companies, Melanie has contributed significantly to research, analysis, and reporting in the biopharma and healthcare sectors. Previous positions include biopharma writer and analyst at EY, senior analyst and writer at Real Endpoints, and bureau chief at Elsevier Business Intelligence, where Melanie expanded European biopharma content. Melanie holds a Bachelor's degree in Natural Sciences from the University of Cambridge and multiple master's degrees in International Health Technology Assessment, Pricing and Reimbursement from The University of Sheffield, and Nutrition Sciences from St Mary’s University, Twickenham.